Published in J Virol on February 04, 2009
Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res (2010) 3.78
The pathogenesis of Rift Valley fever. Viruses (2011) 2.02
Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J Virol (2010) 1.33
Rift valley fever: recent insights into pathogenesis and prevention. J Virol (2011) 1.21
Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res (2012) 1.21
Structural basis for encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein. Proc Natl Acad Sci U S A (2013) 1.19
Crystal structure of glycoprotein C from Rift Valley fever virus. Proc Natl Acad Sci U S A (2013) 1.15
Evolutionary and molecular analysis of the emergent severe fever with thrombocytopenia syndrome virus. Epidemics (2012) 1.10
Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. J Virol (2012) 1.00
Periodic table of virus capsids: implications for natural selection and design. PLoS One (2010) 1.00
Molecular biology of rift valley Fever virus. Open Virol J (2010) 0.98
An assembly model of rift valley Fever virus. Front Microbiol (2012) 0.97
Bunyaviruses and the type I interferon system. Viruses (2009) 0.96
Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. PLoS One (2014) 0.94
Heparan sulfate facilitates Rift Valley fever virus entry into the cell. J Virol (2012) 0.94
Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse. PLoS Negl Trop Dis (2012) 0.92
Phleboviruses and the Type I Interferon Response. Viruses (2016) 0.90
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. J Virol (2015) 0.89
Orthobunyavirus ultrastructure and the curious tripodal glycoprotein spike. PLoS Pathog (2013) 0.87
Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging. J Virol (2014) 0.85
Uukuniemi Phlebovirus assembly and secretion leave a functional imprint on the virion glycome. J Virol (2014) 0.85
Hantavirus Gn and Gc envelope glycoproteins: key structural units for virus cell entry and virus assembly. Viruses (2014) 0.84
Relating structure to evolution in class II viral membrane fusion proteins. Curr Opin Virol (2014) 0.83
Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion. Proc Natl Acad Sci U S A (2016) 0.80
The near-atomic cryoEM structure of a flexible filamentous plant virus shows homology of its coat protein with nucleoproteins of animal viruses. Elife (2015) 0.80
Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs. Future Virol (2014) 0.79
Low pH and Anionic Lipid-dependent Fusion of Uukuniemi Phlebovirus to Liposomes. J Biol Chem (2016) 0.78
RNA Encapsidation and Packaging in the Phleboviruses. Viruses (2016) 0.78
Capsomer dynamics and stabilization in the T = 12 marine bacteriophage SIO-2 and its procapsid studied by CryoEM. Structure (2012) 0.78
Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression. Viruses (2016) 0.78
The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release. Viruses (2016) 0.77
Mechanistic Insight into Bunyavirus-Induced Membrane Fusion from Structure-Function Analyses of the Hantavirus Envelope Glycoprotein Gc. PLoS Pathog (2016) 0.76
An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep. Virol J (2017) 0.75
Early Bunyavirus-Host Cell Interactions. Viruses (2016) 0.75
Structural transitions of the conserved and metastable hantaviral glycoprotein envelope. J Virol (2017) 0.75
Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc Natl Acad Sci U S A (2017) 0.75
Potyvirus virion structure shows conserved protein fold and RNA binding site in ssRNA viruses. Sci Adv (2017) 0.75
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
Solvent content of protein crystals. J Mol Biol (1968) 106.07
EMAN: semiautomated software for high-resolution single-particle reconstructions. J Struct Biol (1999) 27.52
Automated electron microscope tomography using robust prediction of specimen movements. J Struct Biol (2005) 9.78
A model-based approach for determining orientations of biological macromolecules imaged by cryoelectron microscopy. J Struct Biol (1996) 5.39
Bsoft: image processing and molecular modeling for electron microscopy. J Struct Biol (2006) 5.36
Exotic emerging viral diseases: progress and challenges. Nat Med (2004) 4.54
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol (2003) 4.11
Rift Valley fever: an uninvited zoonosis in the Arabian peninsula. Int J Antimicrob Agents (2003) 2.96
Three-dimensional reconstruction of icosahedral particles--the uncommon line. J Struct Biol (1996) 2.91
GraFix: sample preparation for single-particle electron cryomicroscopy. Nat Methods (2007) 2.71
Rift Valley fever outbreak--Kenya, November 2006-January 2007. MMWR Morb Mortal Wkly Rep (2007) 2.63
Three dimensional reconstructions of spherical viruses by fourier synthesis from electron micrographs. Nature (1970) 2.29
RNA binding properties of bunyamwera virus nucleocapsid protein and selective binding to an element in the 5' terminus of the negative-sense S segment. J Virol (2000) 1.96
Membrane proteins modulate the bilayer curvature in the bacterial virus Bam35. Structure (2005) 1.73
Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virology (2006) 1.61
Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein. J Virol (2002) 1.59
Formation and intracellular transport of a heterodimeric viral spike protein complex. J Cell Biol (1991) 1.58
Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J Virol (2008) 1.56
Local average intensity-based method for identifying spherical particles in electron micrographs. J Struct Biol (2000) 1.45
The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging. J Virol (2007) 1.39
Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus. Proc Natl Acad Sci U S A (2008) 1.31
Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses. Virology (2009) 1.23
Golgi complex localization of the Punta Toro virus G2 protein requires its association with the G1 protein. Virology (1991) 1.19
Monosaccharide sequence of protein-bound glycans of Uukuniemi virus. J Virol (1982) 1.19
Generation and analysis of infectious virus-like particles of uukuniemi virus (bunyaviridae): a useful system for studying bunyaviral packaging and budding. J Virol (2006) 1.19
Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies. Arch Virol (1991) 1.16
Oligomerization, transport, and Golgi retention of Punta Toro virus glycoproteins. J Virol (1991) 1.08
The cytoplasmic tails of Uukuniemi Virus (Bunyaviridae) G(N) and G(C) glycoproteins are important for intracellular targeting and the budding of virus-like particles. J Virol (2007) 1.07
Homodimeric association of the spike glycoproteins G1 and G2 of Uukuniemi virus. Virology (1995) 1.03
La Crosse virus G1 glycoprotein undergoes a conformational change at the pH of fusion. Virology (1985) 1.00
RNA binding domain of Jamestown Canyon virus S segment RNAs. J Virol (2007) 0.99
Membrane-containing viruses with icosahedrally symmetric capsids. Curr Opin Struct Biol (2007) 0.96
Electron microscopy of vitrified-hydrated La Crosse virus. J Virol (1987) 0.94
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science (2006) 16.00
The interferon response circuit: induction and suppression by pathogenic viruses. Virology (2006) 4.56
IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol (2011) 4.18
NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol (2004) 3.52
Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ. PLoS Pathog (2006) 2.81
Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell (2007) 2.57
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood (2006) 2.53
Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One (2008) 2.45
NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J Virol (2009) 2.39
The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure (2006) 2.32
Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J Virol (2006) 2.14
Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A (2006) 2.02
Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol (2005) 1.96
Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe (2013) 1.95
Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe (2008) 1.91
La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol (2007) 1.90
Viral immune modulators perturb the human molecular network by common and unique strategies. Nature (2012) 1.86
A resolution criterion for electron tomography based on cross-validation. J Struct Biol (2005) 1.85
Native 3D intermediates of membrane fusion in herpes simplex virus 1 entry. Proc Natl Acad Sci U S A (2008) 1.81
Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog (2007) 1.78
Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem (2004) 1.75
Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog (2010) 1.73
Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J Virol (2005) 1.68
Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J Virol (2003) 1.67
Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol (2005) 1.66
Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev (2007) 1.54
The intracellular sites of early replication and budding of SARS-coronavirus. Virology (2007) 1.53
Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol (2013) 1.52
T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J Gen Virol (2008) 1.50
Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids. J Gen Virol (2003) 1.42
Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol (2013) 1.40
Entry of bunyaviruses into mammalian cells. Cell Host Microbe (2010) 1.40
Cryo electron tomography of native HIV-1 budding sites. PLoS Pathog (2010) 1.39
Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J Virol (2010) 1.33
Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J Med Virol (2007) 1.32
Activation of PKR by Bunyamwera virus is independent of the viral interferon antagonist NSs. J Virol (2003) 1.28
Interferon and cytokine responses to SARS-coronavirus infection. Cytokine Growth Factor Rev (2008) 1.28
Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol (2010) 1.27
The three-dimensional organization of polyribosomes in intact human cells. Mol Cell (2010) 1.26
Eisosome proteins assemble into a membrane scaffold. J Cell Biol (2011) 1.24
Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses. Virology (2009) 1.23
Structural basis for encapsidation of genomic RNA by La Crosse Orthobunyavirus nucleoprotein. Proc Natl Acad Sci U S A (2013) 1.19
Thogoto virus ML protein suppresses IRF3 function. Virology (2005) 1.19
A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. Antiviral Res (2006) 1.19
Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication. J Biol Chem (2012) 1.18
Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. J Biol Chem (2010) 1.17
Structure of Crimean-Congo hemorrhagic fever virus nucleoprotein: superhelical homo-oligomers and the role of caspase-3 cleavage. J Virol (2012) 1.16
Infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1. Proc Natl Acad Sci U S A (2009) 1.16
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog (2011) 1.14
Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus. Virology (2009) 1.13
Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist. J Virol (2003) 1.07
Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J Med Virol (2008) 1.07
Correlative VIS-fluorescence and soft X-ray cryo-microscopy/tomography of adherent cells. J Struct Biol (2011) 1.06
Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity. J Virol (2008) 1.06
Cryo electron tomography of herpes simplex virus during axonal transport and secondary envelopment in primary neurons. PLoS Pathog (2011) 1.05
Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. J Gen Virol (2006) 1.03
The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. J Clin Virol (2004) 1.01
Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. Virol J (2006) 1.01
Conserved eukaryotic fusogens can fuse viral envelopes to cells. Science (2011) 1.01
The structure of herpesvirus fusion glycoprotein B-bilayer complex reveals the protein-membrane and lateral protein-protein interaction. Structure (2013) 1.00
Super-resolution microscopy using standard fluorescent proteins in intact cells under cryo-conditions. Nano Lett (2014) 0.99
Molecular biology of rift valley Fever virus. Open Virol J (2010) 0.98
The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J Virol (2010) 0.97
Bunyaviruses and the type I interferon system. Viruses (2009) 0.96
Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH. J Virol (2014) 0.96
Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines. PLoS Pathog (2011) 0.95
Extracellular 2'-5' oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity. J Virol (2010) 0.95
Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. J Virol (2009) 0.94
Species-independent bioassay for sensitive quantification of antiviral type I interferons. Virol J (2010) 0.93
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. J Gen Virol (2010) 0.93
The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses. J Gen Virol (2011) 0.93
Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination. PLoS One (2012) 0.91
Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J Gen Virol (2009) 0.90
Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus. Vector Borne Zoonotic Dis (2010) 0.90
Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity. Cell Microbiol (2013) 0.88
IFIT2 is an effector protein of type I IFN-mediated amplification of lipopolysaccharide (LPS)-induced TNF-α secretion and LPS-induced endotoxin shock. J Immunol (2013) 0.88
Hiding from intracellular pattern recognition receptors, a passive strategy of flavivirus immune evasion. Virulence (2011) 0.86
La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic. Virology (2010) 0.85
Systems to establish bunyavirus genome replication in the absence of transcription. J Virol (2013) 0.84
Thogoto virus ML protein is a potent inhibitor of the interferon regulatory factor-7 transcription factor. J Gen Virol (2009) 0.84
Old World hantaviruses do not produce detectable amounts of dsRNA in infected cells and the 5' termini of their genomic RNAs are monophosphorylated. J Gen Virol (2011) 0.84
Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines. Vaccine (2012) 0.84
Characterization of herpes simplex virus type 1 L-particle assembly and egress in hippocampal neurones by electron cryo-tomography. Cell Microbiol (2013) 0.81
Inhibition of Dugbe nairovirus replication by human MxA protein. Virus Res (2004) 0.80
The interferon antagonist ML protein of thogoto virus targets general transcription factor IIB. J Virol (2008) 0.80
High-efficiency detection of severe acute respiratory syndrome virus genetic material. J Clin Microbiol (2004) 0.79
Adding a spatial dimension to the proteome. Nat Methods (2009) 0.76
Corrigendum: Correlative in-resin super-resolution and electron microscopy using standard fluorescent proteins. Sci Rep (2016) 0.75
Targeting of viral capsids to nuclear pores in a cell-free reconstitution system. Traffic (2014) 0.75
Interferon interplay helps tissue cells to cope with SARS-coronavirus infection. Virulence (2010) 0.75